<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01351922</url>
  </required_header>
  <id_info>
    <org_study_id>INS-3933</org_study_id>
    <secondary_id>U1111-1120-5710</secondary_id>
    <nct_id>NCT01351922</nct_id>
  </id_info>
  <brief_title>A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India</brief_title>
  <acronym>DiabCare India</acronym>
  <official_title>A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in India and to Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in India (DiabCare India 2011)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novo Nordisk A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is conducted in Asia. The aim of this observational study is to evaluate the
      current status of diabetes management, control, and complications in diabetic subjects in
      India. Perceptions and practices of physicians and subjects about diabetes management will
      also be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean age of onset of type 1 diabetes mellitus</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean age of onset of type 2 diabetes mellitus</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean duration of treatment of type 2 diabetes mellitus</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients on Insulin therapy</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients on Oral Anti-Diabetics Drug (OADs) therapy</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean duration of diabetes in type 1 patients</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean duration of diabetes in type 2 patients</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean FPG (fasting plasma glucose)</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PPG (post prandial glucose)</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HbA1c (Glycosylated Haemoglobin)</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients archiving HbA1c target below or equal 6.5%</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients archiving HbA1c target below or equal 7.0%</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients having complications (dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications)</measure>
    <time_frame>Evaluation visit</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">12000</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No treatment given</intervention_name>
    <description>Patients will fill out a questionaire by interview.</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diabetes mellitus (both type 1 and type 2) being treated at general
        hospitals, diabetes clinics and referral clinics will be selected according to inclusion
        and exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients should have visited the centre at least once in the last 3-6 months apart
             from the initial visit

          -  First twenty patients of diabetes visiting the centre during the data collection
             period

          -  Patients willing to sign the informed consent form

        Exclusion Criteria:

          -  Repetition of any patient as patients should not be included twice for any reason

          -  Unwilling to participate or unable to comply with protocol requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Global Clinical Registry (GCR, 1452)</last_name>
    <role>Study Director</role>
    <affiliation>Novo Nordisk A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <zip>560001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <link>
    <url>http://novonordisk-trials.com</url>
    <description>Clinical Trials at Novo Nordisk</description>
  </link>
  <results_reference>
    <citation>Mohan V, Shah SN, Joshi SR, Seshiah V, Sahay BK, Banerjee S, Wangnoo SK, Kumar A, Kalra S, Unnikrishnan AG, Sharma SK, Rao PV, Akhtar S, Shetty RV, Das AK; DiabCare India 2011 Study Group. Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 Study. Indian J Endocrinol Metab. 2014 May;18(3):370-8. doi: 10.4103/2230-8210.129715.</citation>
    <PMID>24944934</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2011</study_first_submitted>
  <study_first_submitted_qc>May 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2011</study_first_posted>
  <last_update_submitted>January 18, 2017</last_update_submitted>
  <last_update_submitted_qc>January 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

